L-PRF Plus Non Surgical Periodontal Treatment
Effect of Leucocyte and Platelet Rich Fibrin as an Adjuvant in Non-Surgical Periodontal Therapy: A Split-Mouth Randomized Controlled Clinical Trial
1 other identifier
interventional
13
1 country
1
Brief Summary
Abstract: Background: Leucocyte and Platelet-Rich Fibrin (L-PRF) has shown to promote regenerative processes, even reporting antibacterial effect. The aim of this split-mouth clinical trial was to evaluate the effect of L-PRF as an adjuvant to scaling and root planing (SRP). Methods: 13 patients with chronic periodontitis and at least 1 bilateral periodontal pocket ≥ 6 mm were recruited. The sites were randomly treated with SRP + L-PRF (test group) or SRP alone (control group). The following parameters were evaluated at baseline and 6 weeks, 3 and 6 months after treatment: Probing pocket depth (PPD), clinical attachment level (CAL), bleeding on probing (BOP); gingival recession (GR), and root sensitivity (RS). Additionally, the concentrations of Porphyromona gingivalis (P.g), Aggregatibacter actinomycetemcomitans (A.a), Prevotella intermedia (P.i) and Fusobacterium nucleatum (F.n) in the gingival crevicular fluid (GCF) were evaluated at baseline, 6 weeks and 3 months after treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2020
CompletedFirst Submitted
Initial submission to the registry
August 12, 2020
CompletedFirst Posted
Study publicly available on registry
August 20, 2020
CompletedAugust 26, 2020
August 1, 2020
6 months
August 12, 2020
August 22, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change from baseline pocket probing depth at 6 weeks
Change from baseline to 6 weeks of the distance from the gingival margin to the base of the clinical pocket for each site. Unit: millimeters
6 weeks
Change from baseline pocket probing depth at 3 months
Change from baseline to 3 months of the distance from the gingival margin to the base of the clinical pocket for each site. Unit: millimeters
3 months
Change from baseline pocket probing depth at 6 months
Change from baseline to 6 months of the distance from the gingival margin to the base of the clinical pocket for each site. Unit: millimeters
6 months
Secondary Outcomes (18)
Change from baseline clinical attachment level at 6 weeks
6 weeks
Change from baseline clinical attachment level at 3 months
3 months
Change from baseline clinical attachment level at 6 months
6 months
Change from baseline gingival recession at 6 weeks
6 weeks
Change from baseline gingival recession at 3 months
3 months
- +13 more secondary outcomes
Study Arms (2)
NSPT + L-PRF
EXPERIMENTALScaling and root planing associated to Leucocyte and Platelet rich Fibrin Membrane and irrigation with exudate of L-PRF.
NSPT alone
OTHEROnly Scaling and root planing
Interventions
L-PRF membrane and irrigation with L-PRF exudate in the same treatment session of NSPT
The control group only received NSPT (scaling and root planing) in one treatment session.
Eligibility Criteria
You may qualify if:
- age between 30 and 70 years old
- diagnosis of chronic periodontitis
- at least one bilateral periodontal pocket ≥ 6 mm
- healthy patients
You may not qualify if:
- inability to comply with the study protocol
- receiving antibiotic therapy or non-steroidal anti-inflammatory drugs during the previous two months or using calcium channel blockers, phenytoin, cyclosporine, or any associated drug that might affect gingival tissue
- periodontal treatment during the previous 12 months
- auto-immune disorders (self-reported)
- requiring antibiotic prophylaxis before periodontal treatment; or requiring non-steroidal anti-inflammatory drugs for postoperative pain management after periodontal treatment
- smokers \>10 cigarettes
- pregnancy/lactation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad de Los Andes
Santiago, 7550000, Chile
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Catherine Andrade, DDs
Universidad de Los Andes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Only the clinician who provided the treatment knew the treatment assigned. A different clinician performed all the evaluations.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
August 12, 2020
First Posted
August 20, 2020
Study Start
October 30, 2019
Primary Completion
April 30, 2020
Study Completion
May 30, 2020
Last Updated
August 26, 2020
Record last verified: 2020-08